Supernus Pharmaceuticals
SUPN
SUPN
221 hedge funds and large institutions have $1.13B invested in Supernus Pharmaceuticals in 2016 Q3 according to their latest regulatory filings, with 27 funds opening new positions, 83 increasing their positions, 94 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
12% less repeat investments, than reductions
Existing positions increased: 83 | Existing positions reduced: 94
25% less call options, than puts
Call options by funds: $2.17M | Put options by funds: $2.87M
Holders
221
Holding in Top 10
6
Calls
$2.17M
Puts
$2.87M
Top Buyers
| 1 | +$21.1M | |
| 2 | +$7.72M | |
| 3 | +$6.09M | |
| 4 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
+$5.58M |
| 5 |
Allianz Asset Management
Munich,
Germany
|
+$5.49M |
Top Sellers
| 1 | -$20.4M | |
| 2 | -$12.6M | |
| 3 | -$6.88M | |
| 4 |
Millennium Management
New York
|
-$5.79M |
| 5 |
GT
Glenmede Trust
Philadelphia,
Pennsylvania
|
-$5.41M |